US San Fran lawmakers motion to decriminalize psychedelic plants Psychoactive plants like psilocybin mushrooms and ayahuasca will no longer be condemned in California city Rowan DunneSeptember 8, 2022
Psychedelics Xtalks to host upcoming webinar on psychedelic know-how Free virtual conference will discuss unique requisites of psychedelic clinical development Rowan DunneSeptember 7, 2022
Research Psychedelic use rising as the market expands: MicroSmallCap New report outlines statistics and recent accomplishments made in the field Rowan DunneSeptember 6, 2022
Canada Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada Rowan DunneSeptember 2, 2022
International PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies Organization to supply GMP product for second major clinical trial down under this month Rowan DunneAugust 31, 2022
Canada Mindset Pharma discovers 3 novel next-gen psychedelic compounds Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT Rowan DunneAugust 31, 2022
Psychedelics Beond publishes ‘Ibogaine: A Clinical Summary’ Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance Rowan DunneAugust 31, 2022
Canada Cybin administers psychedelic analogue to patients with major depression First novel psilocybin compound to commence clinical development marks 'tremendous milestone' for biotechnology company Rowan DunneAugust 30, 2022
Canada PharmAla Biotech applies for patent on 6 novel MDMA-like molecules Application follows successful pre-clinical animal studies at the University of Arkansas Rowan DunneAugust 29, 2022
Canada Clearmind’s psychoactive drug shows positive results for cocaine use disorder Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency Rowan DunneAugust 26, 2022